Valor202020212022202320242025TTMGastos comerciales, generales y administrativos1.09 B1.33 B772.91 M830.3 M1.03 B1.07 B1.07 BInvestigación y desarrollo——60.83 M75.33 M91.3 M120.33 M120.33 MBeneficio operativo162.29 M256.64 M-71.18 M-65.71 M-775.72 M-1.12 B-1.12 BTotal de ingresos no operativos0-18.66 M12.98 M25.66 M9.89 M-367 K-367 KGastos por intereses, netos de intereses capitalizados104.26 M72.59 M24.05 M19.75 M57.1 M34.82 M34.82 MIngresos no operativos, una vez deducidos los gastos por intereses-104.26 M-91.25 M-13.16 M-19.75 M-57.1 M-34.82 M-34.82 MIngresos/gastos extraordinarios——2.09 M25.66 M9.89 M-367 K-367 KBeneficio antes de impuestos58.03 M165.39 M-2.07 M-67.13 M-822.92 M-1.16 B-1.16 BParticipación en los beneficios—————-600 K—Impuestos-6.05 M66.69 M36.12 M-13.29 M4.49 M22.29 M22.29 MParticipación minoritaria3.15 M4.62 M———-1.18 B-1.18 BOtros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas60.94 M94.07 M-39.72 M-54.37 M-828.1 M-1.18 B-1.18 BOperaciones suspendidas-18.31 M-22.41 M26.43 M21.11 M2.6 M-1.91 M-1.91 MBeneficio neto42.63 M71.66 M-13.29 M-33.26 M-825.49 M-1.18 B-1.18 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas42.63 M71.66 M-13.29 M-33.26 M-825.49 M-1.18 B-1.18 BBeneficio básico por acción0.310.47-0.25-0.61-14.93-20.75-20.75Beneficio por acción diluido0.310.46-0.25-0.61-14.93-20.75-20.75Número medio de acciones ordinarias136.77 M153.42 M54.07 M54.49 M55.28 M57.07 M228.16 MAcciones diluidas138.91 M155.54 M54.07 M54.49 M55.28 M57.07 M228.16 MEBITDA1.2 B1.55 B717.86 M912.54 M1.66 B2.28 B2.12 BEBIT951.77 M1.29 B514.9 M695.43 M730.95 M936.99 M779.36 MCosto de los ingresos1.79 B2.24 B696.27 M711.58 M937.48 M905.82 M905.82 MOtros costes de producción———————Amortización y depreciación (flujo de caja)246.23 M262.92 M202.97 M217.11 M927.83 M1.34 B1.34 B
Enovis Corporation
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.